These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33569771)

  • 1. The impossible quest to make cardiac amyloidosis diagnosis easy.
    Canepa M; Tini G; Montecucco F
    Eur J Clin Invest; 2021 May; 51(5):e13512. PubMed ID: 33569771
    [No Abstract]   [Full Text] [Related]  

  • 2. Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis.
    Treibel TA; Bandula S; Fontana M; White SK; Gilbertson JA; Herrey AS; Gillmore JD; Punwani S; Hawkins PN; Taylor SA; Moon JC
    J Cardiovasc Comput Tomogr; 2015; 9(6):585-92. PubMed ID: 26209459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiac magnetic resonance imaging in amyloidosis].
    Domínguez A; Garrido N; Maceira A
    Rev Esp Cardiol; 2005 Sep; 58(9):1132-3. PubMed ID: 16185629
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of relative sensitivities of noninvasive tests for cardiac amyloidosis in documented cardiac amyloidosis.
    Simons M; Isner JM
    Am J Cardiol; 1992 Feb; 69(4):425-7. PubMed ID: 1734663
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
    Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Images in cardiology. Cardiac amyloidosis].
    Anguita P; García Touchard A; Castro Rd
    Rev Esp Cardiol; 2002 Jul; 55(7):763. PubMed ID: 12113704
    [No Abstract]   [Full Text] [Related]  

  • 7. Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis.
    Kristen AV; Rosenberg M; Lindenmaier D; Merkle C; Steen H; Andre F; Schönland SO; Schnabel PA; Schuster T; Röcken C; Giannitsis E; Katus HA; Frey N
    Amyloid; 2014 Sep; 21(3):202-10. PubMed ID: 25007036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR Imaging and Cardiac Amyloidosis Where to Go From Here?
    Selvanayagam JB; Leong DP
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):165-7. PubMed ID: 20159643
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis.
    Takashio S; Yamamuro M; Izumiya Y; Hirakawa K; Marume K; Yamamoto M; Ueda M; Yamashita T; Ishibashi-Ueda H; Yasuda S; Ogawa H; Ando Y; Anzai T; Tsujita K
    ESC Heart Fail; 2018 Feb; 5(1):27-35. PubMed ID: 28869340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis.
    Dubrey SW; Cha K; Simms RW; Skinner M; Falk RH
    Am J Cardiol; 1996 Feb; 77(4):313-5. PubMed ID: 8607418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ECG findings in elderly patients with and without senile cardiac amyloidosis.
    Cattin L; Melato M; Antonutto G; Mlaoc M; Da Col PG
    J Chronic Dis; 1981; 34(9-10):503-9. PubMed ID: 7276140
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac amyloidosis: combined use of two-dimensional echocardiography and electrocardiography in noninvasive screening before biopsy.
    Sivaram CA; Jugdutt BI; Amy RW; Basualdo CA; Haraphongse M; Shnitka TK
    Clin Cardiol; 1985 Oct; 8(10):511-8. PubMed ID: 4053429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive demonstration of cardiac involvement in acquired forms of systemic amyloidosis.
    Hind CR; Gibson DG; Lavender JP; Pepys MB
    Lancet; 1984 Jun; 1(8391):1417. PubMed ID: 6145870
    [No Abstract]   [Full Text] [Related]  

  • 14. A multi-modal diagnostic model improves detection of cardiac amyloidosis among patients with diagnostic confirmation by cardiac biopsy.
    Zhang KW; Zhang R; Deych E; Stockerl-Goldstein KE; Gorcsan J; Lenihan DJ
    Am Heart J; 2021 Feb; 232():137-145. PubMed ID: 33212046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
    Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
    JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misconceptions and Facts About Cardiac Amyloidosis.
    Nguyen FD; Rodriguez M; Krittanawong C; Witteles R; Lenihan DJ
    Am J Cardiol; 2021 Dec; 160():99-105. PubMed ID: 34610875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The importance of cardiac bio-marker assay for the stratification and monitoring of AL amyloidosis patients -  single center experience].
    Pika T; Lochman P; Vymětal J; Metelka R; Flodr P; Minařík J; Látalová P; Zapletalová J; Bačovský J; Sčudla V
    Vnitr Lek; 2013 Sep; 59(9):776-81. PubMed ID: 24073949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.
    Biolo A; Ramamurthy S; Connors LH; O'Hara CJ; Meier-Ewert HK; Soo Hoo PT; Sawyer DB; Seldin DC; Sam F
    Circ Heart Fail; 2008 Nov; 1(4):249-57. PubMed ID: 19808299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of electro- and echocardiogram for the diagnosis of cardial amyloidosis].
    Klein HH
    Dtsch Med Wochenschr; 1991 Jan; 116(1):13-7. PubMed ID: 1985799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac amyloidosis.
    Yu CH; Lu YH; Lu JH
    QJM; 2019 Feb; 112(2):131-132. PubMed ID: 30476292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.